within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01D_OtherBetaLactamAntibacterials.J01DH51_ImipenemAndCilastatin;

model ImipenemAndCilastatin
  extends Pharmacolibrary.Drugs.ATC.J.J01DH51;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01DH51</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Imipenem and cilastatin is a combination antibiotic approved for treatment of serious bacterial infections, particularly hospital-acquired or complicated infections caused by susceptible organisms. Imipenem is a broad-spectrum beta-lactam carbapenem antibiotic, while cilastatin is a dehydropeptidase inhibitor added to prevent the renal breakdown of imipenem and prolong its antibacterial activity.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects after intravenous administration.</p><h4>References</h4><ol><li><p>Zhanel, GG, et al., &amp; Karlowsky, JA (2007). Comparative review of the carbapenems. <i>Drugs</i> 67(7) 1027–1052. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200767070-00006&quot;>10.2165/00003495-200767070-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17488146/&quot;>https://pubmed.ncbi.nlm.nih.gov/17488146</a></p></li><li><p>Zhanel, GG, et al., &amp; Karlowsky, JA (2019). Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. <i>Drugs</i> 79(3) 271–289. DOI:<a href=&quot;https://doi.org/10.1007/s40265-019-1055-2&quot;>10.1007/s40265-019-1055-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30712199/&quot;>https://pubmed.ncbi.nlm.nih.gov/30712199</a></p></li><li><p>Sagan, O, et al., &amp; Srinivasan, S (2020). Pharmacokinetics and Tolerability of Intravenous Sulbactam-Durlobactam with Imipenem-Cilastatin in Hospitalized Adults with Complicated Urinary Tract Infections, Including Acute Pyelonephritis. <i>Antimicrobial agents and chemotherapy</i> 64(3) –. DOI:<a href=&quot;https://doi.org/10.1128/AAC.01506-19&quot;>10.1128/AAC.01506-19</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31843995/&quot;>https://pubmed.ncbi.nlm.nih.gov/31843995</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end ImipenemAndCilastatin;
